207 related articles for article (PubMed ID: 18283262)
1. Effects of somatostatin on vascular endothelial growth factor (VEGF) secretion from non-functioning pituitary tumoral cells incubated in vitro.
Ławnicka H; Pisarek H; Kunert-Radek J; Pawlikowski M
Neuro Endocrinol Lett; 2008 Feb; 29(1):113-6. PubMed ID: 18283262
[TBL] [Abstract][Full Text] [Related]
2. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.
Pawlikowski M; Lawnicka H; Pisarek H; Kunert-Radek J; Radek M; Culler MD
J Physiol Pharmacol; 2007 Mar; 58(1):179-88. PubMed ID: 17440235
[TBL] [Abstract][Full Text] [Related]
3. Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion.
Zatelli MC; Piccin D; Vignali C; Tagliati F; Ambrosio MR; Bondanelli M; Cimino V; Bianchi A; Schmid HA; Scanarini M; Pontecorvi A; De Marinis L; Maira G; degli Uberti EC
Endocr Relat Cancer; 2007 Mar; 14(1):91-102. PubMed ID: 17395978
[TBL] [Abstract][Full Text] [Related]
4. Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas.
Padova H; Rubinfeld H; Hadani M; Cohen ZR; Nass D; Taylor JE; Culler MD; Shimon I
Mol Cell Endocrinol; 2008 May; 286(1-2):214-8. PubMed ID: 18276067
[TBL] [Abstract][Full Text] [Related]
5. The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the "clinically non-functioning" pituitary adenomas in vitro.
Gruszka A; Kunert-Radek J; Radek A; Pisarek H; Taylor J; Dong JZ; Culler MD; Pawlikowski M
Life Sci; 2006 Jan; 78(7):689-93. PubMed ID: 16115652
[TBL] [Abstract][Full Text] [Related]
6. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
Winczyk K; Kunert-Radek J; Gruszka A; Radek M; Ławnicka H; Pawlikowski M
Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
[TBL] [Abstract][Full Text] [Related]
7. Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1.
Korsisaari N; Ross J; Wu X; Kowanetz M; Pal N; Hall L; Eastham-Anderson J; Forrest WF; Van Bruggen N; Peale FV; Ferrara N
Clin Cancer Res; 2008 Jan; 14(1):249-58. PubMed ID: 18172277
[TBL] [Abstract][Full Text] [Related]
8. Some changes of receptor and postreceptor signal transduction regulated by somatostatin in pituitary hGH-secreting adenomas.
Deng J; Shi Y; Yin J
Chin Med J (Engl); 1997 Sep; 110(9):678-81. PubMed ID: 9642323
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hormone secretion in GH-secreting pituitary adenomas by receptor-subtype specific somatostatin analogues in vitro.
Cap J; Marekova M; Cerman J; Malirova E; Suba P; Netuka D; Hana V; Marek J
Gen Physiol Biophys; 2003 Jun; 22(2):201-12. PubMed ID: 14661732
[TBL] [Abstract][Full Text] [Related]
10. Genetic abnormalities of somatostatin receptors in pituitary tumors.
Lania A; Mantovani G; Spada A
Mol Cell Endocrinol; 2008 May; 286(1-2):180-6. PubMed ID: 17913341
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin and somatostatin receptors in Cushing's disease.
Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.
Danila DC; Haidar JN; Zhang X; Katznelson L; Culler MD; Klibanski A
J Clin Endocrinol Metab; 2001 Jul; 86(7):2976-81. PubMed ID: 11443154
[TBL] [Abstract][Full Text] [Related]
13. 17-beta-estradiol-dependent regulation of somatostatin receptor subtype expression in the 7315b prolactin secreting rat pituitary tumor in vitro and in vivo.
Visser-Wisselaar HA; Van Uffelen CJ; Van Koetsveld PM; Lichtenauer-Kaligis EG; Waaijers AM; Uitterlinden P; Mooy DM; Lamberts SW; Hofland LJ
Endocrinology; 1997 Mar; 138(3):1180-9. PubMed ID: 9048625
[TBL] [Abstract][Full Text] [Related]
14. Relationship between intratumoral hemorrhage and overexpression of vascular endothelial growth factor (VEGF) in pituitary adenoma.
Arita K; Kurisu K; Tominaga A; Sugiyama K; Eguchi K; Hama S; Yoshioka H; Yamasaki F; Kanou Y
Hiroshima J Med Sci; 2004 Jun; 53(2):23-7. PubMed ID: 15453394
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland.
Ueberberg B; Tourne H; Redmann A; Walz MK; Schmid KW; Mann K; Petersenn S
Horm Metab Res; 2005 Dec; 37(12):722-8. PubMed ID: 16372224
[TBL] [Abstract][Full Text] [Related]
16. Role of somatostatin receptors in normal and tumoral pituitary corticotropic cells.
Hofland LJ; Lamberts SW; Feelders RA
Neuroendocrinology; 2010; 92 Suppl 1():11-6. PubMed ID: 20829612
[TBL] [Abstract][Full Text] [Related]
17. In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists.
Bocci G; Culler MD; Fioravanti A; Orlandi P; Fasciani A; Colucci R; Taylor JE; Sadat D; Danesi R; Del Tacca M
Eur J Clin Invest; 2007 Sep; 37(9):700-8. PubMed ID: 17696959
[TBL] [Abstract][Full Text] [Related]
18. Pituitary tumours: the sst/D2 receptors as molecular targets.
Hofland LJ; Feelders RA; de Herder WW; Lamberts SW
Mol Cell Endocrinol; 2010 Sep; 326(1-2):89-98. PubMed ID: 20438803
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro.
Lohrer P; Gloddek J; Hopfner U; Losa M; Uhl E; Pagotto U; Stalla GK; Renner U
Neuroendocrinology; 2001 Aug; 74(2):95-105. PubMed ID: 11474217
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of nestin in the non-tumorous hypophysis and in pituitary neoplasms.
Rotondo F; Kovacs K; Horvath E; Bell CD; Lloyd RV; Scheithauer BW
Acta Neuropathol; 2006 Mar; 111(3):272-7. PubMed ID: 16538520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]